Performance Indicators

Performance indicators of the Journal of Basic and Applied Pharmaceutical Sciences (updated in December 2021)

Figure 1. Average time between submission and publication of the manuscript in the Journal of Basic and Applied Pharmaceutical Sciences in 2021.

Figure 2. Index of manuscripts accepted for publication in the Journal of Basic and Applied Pharmaceutical Sciences.

 

Table 1. Performance indicators of the Journal of Basic and Applied Pharmaceutical Sciences through 2021.

Indicator

Number
(N/days/%)

Index of manuscripts rejected by Editors

29.5

Index of manuscripts rejected by Reviewer

35.5

Number of collaborators (reviewers)

45

Average of reviews per manuscript

6.8

Average of reviewers per manuscript

4.9

Percentage of endogeny (since 2005)

35.2

Index of foreign correspondence manuscripts (Spain, Portugal, Nigeria, India, United States of America, Italy, Uruguay, Paraguay, Argentina, Colombia, and Cuba)

0.3


N: number

Table 2. Indicators of the Journal of Basic and Applied Pharmaceutical Sciences considering indexing databases, number of cited documents and H index.

Database

Number of cited documents

H index

Scopus

407

16

Google Scholar

8.037

39

Google Scholar H10

8.037

260

Google Scholar 2016 - 2021

5.161

30

Google Scholar H10 2016 - 2021

5.161

171


 

Performance indicators of social networks of the Journal of Basic and Applied Pharmaceutical Sciences and respective metrics.

Table 1. Description of social networks of the Journal of Basic and Applied Pharmaceutical Sciences and respective posting metrics, coverage, views, reach, impression, and interactions.


Social network


Post (N)


Coverage


View/reach/impression


Sharing/reaction/comment

Facebook

62

345

1 to 19,308

0 to 1,570

LinkedIn

62

316

0 to 8,580

0 to 339

Instagram

62

108

0 to 410

0 to 402

Twitter

18

1

0 to 100

0 to 17


N: number

https://www.facebook.com/Scientific.Communication.RCFBA/

https://www.linkedin.com/company/69484728/admin/

https://www.instagram.com/scientific.communication.rcfba/?hl=pt-br

https://twitter.com/rev_apl